Revenue
2022
2023
2024
2025
Vsee Health, Inc. (VSEED)
Price—Loading quote
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $14.6M | $10.4M | $5.8M | $6.4M | N/A |
| Gross profit | $7.4M | $7.2M | $3.8M | $4.8M | N/A |
| Gross margin | 50.32% | 68.87% | 66.47% | 75.81% | N/A |
| Operating expenses | $16.9M | $69.3M | $5.7M | $3.6M | N/A |
| Operating income | −$9.6M | −$62.2M | −$1.9M | −$3.6M | N/A |
| Operating margin | −65.55% | −596.38% | −32.49% | −56.37% | N/A |
| EBITDA | −$7.0M | −$60.8M | −$1.9M | −$1.6M | N/A |
| EBITDA margin | −47.85% | −583.68% | −32.48% | −24.90% | N/A |
| Net income | −$14.7M | −$57.7M | −$3.8M | −$3.2M | N/A |
| Net profit margin | −100.65% | −553.69% | −65.26% | −50.84% | N/A |
| Basic EPSper basic share | -$11,680.00 | -$90,400.00 | -$15,200.00 | -$25,000.00 | $0.03 |
| Diluted EPSper diluted share | -$11,680.00 | -$90,400.00 | -$15,200.00 | -$25,000.00 | $0.03 |
Owners
Reported shareholders